Candidiasis y otras enfermedades infecciosas asociadas con biopelículas (CanBIO) - GIC 21/024
Hospital Universitario de Valme
Sevilla, EspañaPublications in collaboration with researchers from Hospital Universitario de Valme (20)
2022
-
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
Frontiers in Cellular and Infection Microbiology, Vol. 12
2019
-
Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre Yeastone colorimetric broth and etest agar diffusion methods
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 1
2018
-
Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis
Medical Mycology, Vol. 56, pp. S42-S59
2012
-
Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1181-1187
2011
-
Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454
-
Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia
Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 12, pp. 5590-5596
-
Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update
Enfermedades Infecciosas y Microbiologia Clinica
2010
2007
-
Update on invasive fungal infections: the last two years
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 19-27
2004
-
In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts
Revista Iberoamericana de Micologia, Vol. 21, Núm. 2, pp. 63-69
2002
2000
-
Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole
Chemotherapy, Vol. 46, Núm. 4, pp. 235-244
-
In vitro activity of a new liposomal nystatin formulation against opportunistic fungal pathogens
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 19, Núm. 8, pp. 645-648
-
In vitro susceptibility of Candida dubliniensis to current and new antifungal agents
Chemotherapy, Vol. 46, Núm. 6, pp. 395-401
-
Sensibilidad a fluconazol e itraconazol en aislamientos de Candida spp. procedentes de pacientes VIH positivos y VIH negativos
Revista Espanola de Quimioterapia, Vol. 13, Núm. 1, pp. 60-63
1999
-
A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.
Journal of Antimicrobial Chemotherapy, Vol. 43, Núm. 4, pp. 477-481
-
In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients
Journal of Antimicrobial Chemotherapy, Vol. 44, Núm. 5, pp. 697-700
-
Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing
Revista Iberoamericana de Micologia, Vol. 16, Núm. 2, pp. 92-96
-
Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients
Revista Iberoamericana de Micologia, Vol. 16, Núm. 2, pp. 97-100
1996
-
Aportaciones del comité de la AEM para la estandarización de pruebas de estudio de la sensibilidad in vitro a los antifúngicos: Método de difusión en disco
Revista Iberoamericana de Micologia, Vol. 13, Núm. SUPPL. 2